Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2023-07-11 2023-07-11
Drug Identification Number 02250292 02250292
Brand name CEFTRIAXONE SODIUM FOR INJECTION BP CEFTRIAXONE SODIUM FOR INJECTION BP
Common or Proper name CEFTRIAXONE SODIUM FOR INJECTION BP CEFTRIAXONE SODIUM FOR INJECTION BP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CEFTRIAXONE CEFTRIAXONE
Strength(s) 1G 1G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1g vial 10 x 1g vial
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2023-07-10 2023-07-10
Remaining supply date 2023-07-10 2023-07-10
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments